GSK-4077164A

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameGSK-4077164A
Drug Alias NameGVGH iNTS-GMMA Vaccine (Glaxosmithkline)iNTS-typhoid conjugate vaccine (Glaxosmithkline)GSK-4077164AiNTSiNTS-TCV +[6] 
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSalmonella Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumMalawiGhana
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsSalmonella Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A